S. de Kimpe

778 total citations
18 papers, 598 citations indexed

About

S. de Kimpe is a scholar working on Molecular Biology, Immunology and Nephrology. According to data from OpenAlex, S. de Kimpe has authored 18 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Immunology and 2 papers in Nephrology. Recurrent topics in S. de Kimpe's work include Muscle Physiology and Disorders (8 papers), RNA Interference and Gene Delivery (5 papers) and interferon and immune responses (2 papers). S. de Kimpe is often cited by papers focused on Muscle Physiology and Disorders (8 papers), RNA Interference and Gene Delivery (5 papers) and interferon and immune responses (2 papers). S. de Kimpe collaborates with scholars based in Netherlands, United States and Sweden. S. de Kimpe's co-authors include Christoph Thiemermann, Simon J. Foster, Caroline D. Robson, Annemieke Aartsma‐Rus, Hans Heemskerk, Gert‐Jan B. van Ommen, Peter A.C. ’t Hoen, C.L. de Winter, Anneke A. M. Janson and Laura Van de Vliet and has published in prestigious journals such as The Journal of Experimental Medicine, Neurology and International Journal of Molecular Sciences.

In The Last Decade

S. de Kimpe

17 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. de Kimpe Netherlands 9 385 159 73 67 64 18 598
Benedikt Kirchner Germany 17 689 1.8× 138 0.9× 12 0.2× 63 0.9× 66 1.0× 43 1.0k
Eva Kaiser Germany 11 311 0.8× 316 2.0× 19 0.3× 73 1.1× 60 0.9× 16 713
Xiaolin Tang China 18 189 0.5× 76 0.5× 21 0.3× 32 0.5× 63 1.0× 46 695
Alessio Branchini Italy 17 345 0.9× 22 0.1× 64 0.9× 53 0.8× 32 0.5× 45 700
Urszula Wojewódzka Poland 14 198 0.5× 77 0.5× 53 0.7× 33 0.5× 60 0.9× 25 676
Gholam Ali Kardar Iran 14 138 0.4× 254 1.6× 28 0.4× 71 1.1× 66 1.0× 54 628
Ali Khammanivong United States 16 406 1.1× 148 0.9× 8 0.1× 45 0.7× 103 1.6× 30 697
Denis Polančec Croatia 13 128 0.3× 106 0.7× 69 0.9× 21 0.3× 89 1.4× 25 538
Michael Diegel United States 11 143 0.4× 264 1.7× 25 0.3× 58 0.9× 59 0.9× 15 549

Countries citing papers authored by S. de Kimpe

Since Specialization
Citations

This map shows the geographic impact of S. de Kimpe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. de Kimpe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. de Kimpe more than expected).

Fields of papers citing papers by S. de Kimpe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. de Kimpe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. de Kimpe. The network helps show where S. de Kimpe may publish in the future.

Co-authorship network of co-authors of S. de Kimpe

This figure shows the co-authorship network connecting the top 25 collaborators of S. de Kimpe. A scholar is included among the top collaborators of S. de Kimpe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. de Kimpe. S. de Kimpe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Reutelingsperger, Chris, Marion J. Gijbels, Henri M.H. Spronk, et al.. (2024). M6229 Protects against Extracellular-Histone-Induced Liver Injury, Kidney Dysfunction, and Mortality in a Rat Model of Acute Hyperinflammation. International Journal of Molecular Sciences. 25(3). 1376–1376. 4 indexed citations
2.
Parma, Laura, Hendrika A. B. Peters, Maria E. Johansson, et al.. (2020). Bis(maltolato)oxovanadium(IV) Induces Angiogenesis via Phosphorylation of VEGFR2. International Journal of Molecular Sciences. 21(13). 4643–4643. 4 indexed citations
3.
Bosgra, Sieto, Jessica A. Sipkens, S. de Kimpe, et al.. (2019). The Pharmacokinetics of 2′- O -Methyl Phosphorothioate Antisense Oligonucleotides: Experiences from Developing Exon Skipping Therapies for Duchenne Muscular Dystrophy. Nucleic Acid Therapeutics. 29(6). 305–322. 22 indexed citations
4.
McDonald, Craig M., Brenda Wong, Kevin M. Flanigan, et al.. (2018). Placebo‐controlled Phase 2 Trial of Drisapersen for Duchenne Muscular Dystrophy. Annals of Clinical and Translational Neurology. 5(8). 913–926. 29 indexed citations
5.
Giannakopoulos, Stavros, et al.. (2015). Identification of Serum Biomarkers for Duchenne Muscular Dystrophy (P2.239). Neurology. 84(14_supplement). 1 indexed citations
6.
Putten, Maaike van, Courtney S. Young, Sjoerd A.A. van den Berg, et al.. (2014). Preclinical Studies on Intestinal Administration of Antisense Oligonucleotides as a Model for Oral Delivery for Treatment of Duchenne Muscular Dystrophy. Molecular Therapy — Nucleic Acids. 3. e211–e211. 14 indexed citations
7.
Aartsma‐Rus, Annemieke, Peter A.C. ’t Hoen, Cor Breukel, et al.. (2013). Inhibition of IL-1 Signaling by Antisense Oligonucleotide-mediated Exon Skipping of IL-1 Receptor Accessory Protein (IL-1RAcP). Molecular Therapy — Nucleic Acids. 2. e66–e66. 17 indexed citations
8.
9.
Beekman, Chantal, Stavros Giannakopoulos, Jessica A. Sipkens, et al.. (2013). P.13.12 An objective method for immunofluorescence analysis of dystrophin levels in muscle from DMD patients in clinical studies. Neuromuscular Disorders. 23(9-10). 812–812. 2 indexed citations
10.
Aartsma‐Rus, Annemieke, Anne Vroon, J. van Deutekom, et al.. (2012). Antisense oligonucleotide mediated exon skipping as a potential strategy for the treatment of a variety of inflammatory diseases such as rheumatoid arthritis. Annals of the Rheumatic Diseases. 71. i75–i77. 7 indexed citations
11.
Goemans, Nathalie, M. Tulinius, R. Wilson, et al.. (2011). 2FC2.1 Phase I/IIa Extension Study of PRO051/GSK2402968 in Subjects with Duchenne Muscular Dystrophy: Forty-Eight Week Safety and Efficacy Data. European Journal of Paediatric Neurology. 15. S19–S20.
12.
Heemskerk, Hans, Patrizia Sabatelli, Paola Rimessi, et al.. (2010). Preclinical PK and PD Studies on 2′-O-Methyl-phosphorothioate RNA Antisense Oligonucleotides in the mdx Mouse Model. Molecular Therapy. 18(6). 1210–1217. 114 indexed citations
13.
Goemans, Nathalie, M. Tulinius, Gunnar Buyse, et al.. (2010). O.15 24 week follow-up data from a phase I/IIa extension study of PRO051/GSK2402968 in subjects with Duchenne muscular dystrophy. Neuromuscular Disorders. 20(9-10). 639–639. 6 indexed citations
14.
Aartsma‐Rus, Annemieke, Laura Van de Vliet, Marscha Hirschi, et al.. (2008). Guidelines for Antisense Oligonucleotide Design and Insight Into Splice-modulating Mechanisms. Molecular Therapy. 17(3). 548–553. 112 indexed citations
15.
Janson, Annika, Annemieke Aartsma‐Rus, G.J.B. van Ommen, et al.. (2006). T.O. 1 Antisense-induced exon skipping in Duchenne muscular dystrophy patients. Neuromuscular Disorders. 16(9-10). 722–722. 1 indexed citations
16.
Kimpe, S. de, et al.. (2001). Albumin restores lysophosphatidylcholine-induced inhibition of vasodilation in rat aorta. Kidney International. 60(3). 1088–1096. 25 indexed citations
17.
18.
Kimpe, S. de, et al.. (1997). NITRIC OXIDE RATHER THAN PEROXYNITRITE CONTRIBUTES TO THE LOSS OF VIABILTY IN MACROPHAGES AFTER GRAM POSITIVE CELL WALL COMPONENTS. The Japanese Journal of Pharmacology. 75. 102–102. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benedikt Kirchner Breakdown of academic impact, for papers by Eva Kaiser Breakdown of academic impact, for papers by Xiaolin Tang Breakdown of academic impact, for papers by Alessio Branchini Breakdown of academic impact, for papers by Urszula Wojewódzka Breakdown of academic impact, for papers by Gholam Ali Kardar Breakdown of academic impact, for papers by Ali Khammanivong Breakdown of academic impact, for papers by Denis Polančec Breakdown of academic impact, for papers by Michael Diegel
Rankless by CCL
2026